These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 26055376

  • 1. Pharmacodynamic Profile of GSK2140944 against Methicillin-Resistant Staphylococcus aureus in a Murine Lung Infection Model.
    So W, Crandon JL, Nicolau DP.
    Antimicrob Agents Chemother; 2015 Aug; 59(8):4956-61. PubMed ID: 26055376
    [Abstract] [Full Text] [Related]

  • 2. In Vivo Pharmacodynamic Target Assessment of Delafloxacin against Staphylococcus aureus, Streptococcus pneumoniae, and Klebsiella pneumoniae in a Murine Lung Infection Model.
    Lepak AJ, Andes DR.
    Antimicrob Agents Chemother; 2016 Aug; 60(8):4764-9. PubMed ID: 27216072
    [Abstract] [Full Text] [Related]

  • 3. In Vivo Pharmacodynamic Target Investigation of Two Bacterial Topoisomerase Inhibitors, ACT-387042 and ACT-292706, in the Neutropenic Murine Thigh Model against Streptococcus pneumoniae and Staphylococcus aureus.
    Lepak AJ, Seiler P, Surivet JP, Ritz D, Kohl C, Andes DR.
    Antimicrob Agents Chemother; 2016 Jun; 60(6):3626-32. PubMed ID: 27044547
    [Abstract] [Full Text] [Related]

  • 4. Pharmacokinetic-Pharmacodynamic Evaluation of Gepotidacin against Gram-Positive Organisms Using Data from Murine Infection Models.
    Bulik CC, Okusanya ÓO, Lakota EA, Forrest A, Bhavnani SM, Hoover JL, Andes DR, Ambrose PG.
    Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27872075
    [Abstract] [Full Text] [Related]

  • 5. Pharmacodynamics of tigecycline against phenotypically diverse Staphylococcus aureus isolates in a murine thigh model.
    Crandon JL, Banevicius MA, Nicolau DP.
    Antimicrob Agents Chemother; 2009 Mar; 53(3):1165-9. PubMed ID: 19114676
    [Abstract] [Full Text] [Related]

  • 6. Pharmacodynamic and pharmacokinetic profiling of delafloxacin in a murine lung model against community-acquired respiratory tract pathogens.
    Thabit AK, Crandon JL, Nicolau DP.
    Int J Antimicrob Agents; 2016 Nov; 48(5):535-541. PubMed ID: 27742208
    [Abstract] [Full Text] [Related]

  • 7. Pharmacodynamic activity of ceftobiprole compared with vancomycin versus methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-intermediate Staphylococcus aureus (VISA) and vancomycin-resistant Staphylococcus aureus (VRSA) using an in vitro model.
    Zhanel GG, Voth D, Nichol K, Karlowsky JA, Noreddin AM, Hoban DJ.
    J Antimicrob Chemother; 2009 Aug; 64(2):364-9. PubMed ID: 19454524
    [Abstract] [Full Text] [Related]

  • 8. In Vivo Pharmacodynamics of Omadacycline against Staphylococcus aureus in the Neutropenic Murine Thigh Infection Model.
    Lepak AJ, Zhao M, Marchillo K, VanHecker J, Andes DR.
    Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 31036691
    [Abstract] [Full Text] [Related]

  • 9. Pharmacodynamics of a new cephalosporin, PPI-0903 (TAK-599), active against methicillin-resistant Staphylococcus aureus in murine thigh and lung infection models: identification of an in vivo pharmacokinetic-pharmacodynamic target.
    Andes D, Craig WA.
    Antimicrob Agents Chemother; 2006 Apr; 50(4):1376-83. PubMed ID: 16569855
    [Abstract] [Full Text] [Related]

  • 10. Comparative Pharmacodynamics of Telavancin and Vancomycin in the Neutropenic Murine Thigh and Lung Infection Models against Staphylococcus aureus.
    Lepak AJ, Zhao M, Andes DR.
    Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28416551
    [Abstract] [Full Text] [Related]

  • 11. Pharmacokinetic/Pharmacodynamic Evaluation of a Novel Aminomethylcycline Antibiotic, KBP-7072, in the Neutropenic Murine Pneumonia Model against Staphylococcus aureus and Streptococcus pneumoniae.
    Lepak AJ, Zhao M, Liu Q, Wang P, Wang Y, Bader JC, Ambrose PG, Andes DR.
    Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30559140
    [Abstract] [Full Text] [Related]

  • 12. In vivo pharmacokinetics and pharmacodynamics of the lantibiotic NAI-107 in a neutropenic murine thigh infection model.
    Lepak AJ, Marchillo K, Craig WA, Andes DR.
    Antimicrob Agents Chemother; 2015 Feb; 59(2):1258-64. PubMed ID: 25512404
    [Abstract] [Full Text] [Related]

  • 13. Comparative efficacies of human simulated exposures of telavancin and vancomycin against methicillin-resistant Staphylococcus aureus with a range of vancomycin MICs in a murine pneumonia model.
    Crandon JL, Kuti JL, Nicolau DP.
    Antimicrob Agents Chemother; 2010 Dec; 54(12):5115-9. PubMed ID: 20837760
    [Abstract] [Full Text] [Related]

  • 14. [The change and significance of vancomycin minimal inhibitory concentration against methicillin-resistant Staphylococcus aureus isolates from inpatients with lower respiratory tract infection].
    Yang W, He B, Ning YZ, Li Y.
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 Apr; 36(4):288-92. PubMed ID: 23945344
    [Abstract] [Full Text] [Related]

  • 15. Synthesis and pharmacological evaluations of 4-hydroxycoumarin derivatives as a new class of anti-Staphylococcus aureus agents.
    Li ZP, Li J, Qu D, Hou Z, Yang XH, Zhang ZD, Wang YK, Luo XX, Li MK.
    J Pharm Pharmacol; 2015 Apr; 67(4):573-82. PubMed ID: 25556550
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Pharmacodynamic profile of daptomycin against Enterococcus species and methicillin-resistant Staphylococcus aureus in a murine thigh infection model.
    Dandekar PK, Tessier PR, Williams P, Nightingale CH, Nicolau DP.
    J Antimicrob Chemother; 2003 Sep; 52(3):405-11. PubMed ID: 12917254
    [Abstract] [Full Text] [Related]

  • 19. Pharmacokinetics/Pharmacodynamics of Pulmonary Delivery of Colistin against Pseudomonas aeruginosa in a Mouse Lung Infection Model.
    Lin YW, Zhou QT, Cheah SE, Zhao J, Chen K, Wang J, Chan HK, Li J.
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28031207
    [Abstract] [Full Text] [Related]

  • 20. Comparative In Vivo Efficacies of Tedizolid in Neutropenic versus Immunocompetent Murine Streptococcus pneumoniae Lung Infection Models.
    Abdelraouf K, Nicolau DP.
    Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27799200
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.